The Cooper Companies, Inc. (NASDAQ:COO) Given Consensus Recommendation of “Moderate Buy” by Brokerages

The Cooper Companies, Inc. (NASDAQ:COO) has earned a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is $100.38.

COO has been the topic of a number of analyst reports. Wall Street Zen downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Saturday, June 7th. BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Wells Fargo & Company dropped their price target on shares of Cooper Companies from $118.00 to $93.00 and set an “overweight” rating for the company in a research report on Friday, May 30th. Citigroup dropped their price target on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Friday, March 7th. Finally, Stifel Nicolaus dropped their price target on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Friday, March 7th.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of Cooper Companies in the fourth quarter valued at approximately $691,000. Entropy Technologies LP acquired a new position in shares of Cooper Companies in the fourth quarter valued at approximately $248,000. Lecap Asset Management Ltd. grew its holdings in Cooper Companies by 33.1% during the 4th quarter. Lecap Asset Management Ltd. now owns 11,955 shares of the medical device company’s stock worth $1,099,000 after acquiring an additional 2,974 shares in the last quarter. Apollon Wealth Management LLC acquired a new position in Cooper Companies during the 4th quarter worth approximately $200,000. Finally, Figure 8 Investment Strategies LLC acquired a new position in Cooper Companies during the 4th quarter worth approximately $1,360,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Performance

NASDAQ:COO opened at $69.70 on Friday. The company’s 50-day moving average price is $77.93 and its 200-day moving average price is $86.25. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company has a market cap of $13.94 billion, a P/E ratio of 35.74, a P/E/G ratio of 2.25 and a beta of 0.98. Cooper Companies has a twelve month low of $65.00 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. During the same period in the previous year, the firm earned $0.85 earnings per share. Cooper Companies’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, sell-side analysts forecast that Cooper Companies will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.